Abstract:Recently, targeted degradation has emerged as a powerful therapeutic modality. Relying on "event-driven" pharmacology, proteolysis targeting chimeras (PROTACs) can degrade targets and are superior to conventional inhibitors against undruggable proteins. Unfortunately, PROTAC discovery is limited by warhead scarcity and laborious optimization campaigns. To address these shortcomings, analogous protein-based heterobifunctional degraders, known as bioPROTACs, have been developed. Compared to small-molecule PROTACs, bioPROTACs have higher success rates and are subject to fewer design constraints. However, the membrane impermeability of proteins severely restricts bioPROTAC deployment as a generalized therapeutic modality. Here, we present an engineered bioPROTAC template able to complex with cationic and ionizable lipids via electrostatic interactions for cytosolic delivery. When delivered by biocompatible lipid nanoparticles, these modified bioPROTACs can rapidly degrade intracellular proteins, exhibiting near-complete elimination (up to 95% clearance) of targets within hours of treatment. Our bioPROTAC format can degrade proteins localized to various subcellular compartments including the mitochondria, nucleus, cytosol, and membrane. Moreover, substrate specificity can be easily reprogrammed, allowing modular design and targeting of clinically-relevant proteins such as Ras, Jnk, and Erk. In summary, this work introduces an inexpensive, flexible, and scalable platform for efficient intracellular degradation of proteins that may elude chemical inhibition.

Protease-Responsive Toolkit for Conditional Targeted Protein Degradation

PROTACs: an Emerging Targeting Technique for Protein Degradation in Drug Discovery

Lipid-mediated intracellular delivery of recombinant bioPROTACs for the rapid degradation of undruggable proteins

Precise Modulation of Protein Degradation by Smart PROTACs

Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation

Stimuli‐Responsive PROTACs for Controlled Protein Degradation

Advancing Proteolysis Targeting Chimera (PROTAC) Nanotechnology in Protein Homeostasis Reprograming for Disease Treatment

Opportunities and Challenges of Small Molecule Induced Targeted Protein Degradation

A modular PROTAC design for target destruction using a degradation signal based on a single amino acid

In Vivo Target Protein Degradation Induced by PROTACs Based on E3 Ligase DCAF15

PROTACs: Emerging Targeted Protein Degradation Approaches for Advanced Druggable Strategies

Delivering on Cell‐Selective Protein Degradation Using Chemically Tailored PROTACs

Proteolysis-targeting chimera (PROTAC) for targeted protein degradation and cancer therapy

Advances in Protein Degradation

Efficient PROTAC-ing: combinational use of PROTACs with signaling pathway inhibitors

[Induced degradation of proteins by PROTACs and other strategies: towards promising drugs]

Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety

Stimuli-activatable PROTACs for precise protein degradation and cancer therapy

Degron-based bioPROTACs for controlling signaling in CAR T cells

Targeted protein degradation: mechanisms, strategies and application

Light-Controllable PROTACs for Temporospatial Control of Protein Degradation